Cancer researchers (IMAGE)

Virginia Tech

Cancer researchers

Caption

Using CRISPR gene editing, Kathleen Mulvaney (center), an assistant professor with the Fralin Biomedical Research Institute, revealed a combination of therapies that showed promise in treating cancer in preclinical models. The study in the journal Cancer Research could help guide development of new therapies for some treatment-resistant lung, brain, and pancreatic cancers. Her lab members and colleagues include (from left) Samar Sayedyahossein, Diya Chhabra, Caleb Townsend, Eliana Destefanis; Dr. Erhumuoghene “Mary” Enakireru, Blanka Bordas, Samuel Moffitt, and Cole Simon.

Credit

Samantha Pipken/Virginia Tech

Usage Restrictions

For use with related story

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.